Late last month, tens of thousands of Japanese citizens took to the streets to protest the government's plan to rollout a 'self-amplifying' mRNA COVID vaccine, which experts have warned lacks long-term safety data.
Ultra-low fees kept monetization in the basis-point range, leaving revenue unable to offset steep losses despite surging Hong Kong trading volumes.
...